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1155-99 Similar Clinical Outcomes for Sirolimus-Eluting Stent 
Implantation and Coronary Brachytherapy for the 
Treatment of In-Stent Restenosis
Francesco Saia, Pedro A. Lemos, Angela Hoye, Georgios Sianos, Chourmouzios A. 
Arampatzis, Willem J. van der Giessen, Pieter C. Smits, Ron T. van Domburg, Pim J. de 
Feyter, Patrick W. Serruys, Erasmus University Medical Center, Rotterdam, The 
Netherlands
Background: Preliminary studies have shown that sirolimus-eluting stent (SES) implan-
tation is safe and effective for the treatment of in-stent restenosis (ISR). However, the
clinical efficacy of this new therapeutic approach has not been compared to coronary
brachytherapy (CBT), the best treatment currently available for ISR.
Methods: We assessed the incidence of major adverse cardiac events (MACE = death,
myocardial infarction, target lesion revascularization) in 43 consecutive patients treated
with CBT at our institution for ISR (CBT group) and 44 consecutive patients with ISR,
without prior irradiation of the target vessel, treated with SES implantation (SES group).
Results: Baseline clinical characteristics of the two groups were similar. Relatively more
ISR lesions per patient were treated in the SES group (1.2±0.5 versus 1.0±0.2; p=0.02).
Angiographically, the prevalence of Mehran class I and II lesions was similar among the
two groups (66% CBT versus 63% SES; p=0.7). In the CBT group periprocedural glyco-
protein IIb/IIIa inhibitors utilization was more common (33% versus 9%; p=0.007), and
clopidogrel prescription longer (7.5±5.5 months vs 5.9±2.6 months; p=0.005). During 9
months of follow-up, 3 patients (7%) died in the CBT group and 0 in the SES group. The
incidence of myocardial infarction was 2.3% in both groups. Target lesion revasculariza-
tion was performed in 11.6% of the CBT patients and 16.3% of the SES patients (p=ns).
The 9-month MACE-free survival was similar in both groups (79.1% CBT versus 81.5%
SES; p=0.8 by log rank).
Conclusions: This non-randomized study suggests that sirolimus-eluting stent implanta-
tion is as effective as vascular brachytherapy in the treatment of in-stent restenosis.
1155-100 Intracoronary Radiation Therapy Using a Novel Beta 
Emitter for In-Stent Restenosis: Tungsten WRIST
Ron Waksman, Andrew E. Ajani, Christian E. Dilcher, Janice K. Lavoie, Rebecca 
Torguson, Afework GebreEyesus, Rosanna C. Chan, Michael Porrazzo, Lowell F. Satler, 
William O. Suddath, Augusto D. Pichard, Kenneth M. Kent, Joseph Lindsay, Washington 
Hospital Center, Washington, DC
Background: Tungsten WRIST is a safety and feasibility study of intracoronary radiation
therapy utilizing Tungsten (188W), a beta emitter. In animal studies, 188W has achieved
effective reduction of neointimal proliferation with doses up to 25 Gy at 2mm.
Methods: Thirty patients (pts) with in-stent restenosis (ISR) of native coronary arteries
were treated with PCI (balloon angioplasty, rotational atherectomy, laser ablation, or addi-
tional stenting) and intracoronary radiation with 188W. The Tungsten source with an active
length of 33mm (total length 40mm, diameter 1mm) was manually delivered over a
guidewire. The prescription doses were 18 Gy (n=10), 22 Gy (n=10), and 25 Gy (n=10) at
2mm radial distance from the center of the source. All pts received lifelong aspirin and
clopidogrel for at least 6 months.
Results: Pts were: male 67%, diabetics 43%; and age 58 + 12 yrs. ISR lesions involved
the LAD in 67% of the cases. Preprocedure reference vessel diameter was 2.69±0.46mm
and lesion length was 16.09±6.91mm. In 7%, an additional stent was used. Balloon
angioplasty alone was done in 47% of pts. In all pts radiation was successfully given with
no procedural complications. All pts completed 6-month follow-up. There were no differ-
ences in angiographic restenosis.
Conclusions: Intracoronary delivery of the Tungsten source was feasible and safe.
Doses of 18-25 Gy were associated with similar clinical events when compared with
other beta and gamma emitters used in clinical practice for the treatment of ISR. 
1155-101 In Vivo Temperature Measurements of Human 
Atherosclerotic Plaques With a New Balloon-
Thermography Catheter: The “Cooling Effect” of Blood 
Flow
Eleftherios Tsiamis, Konstantinos Toutouzas, John Mitropoulos, Sophia Vaina, Manolis 
Vavuranakis, Costas Tsioufis, John Kallikazaros, Christos Pitsavos, Christodoulos 
Stefanadis, Hippokration Hospital, Athens, Greece
Background: Ex vivo and in vivo temperature measurements of the human atheroscle-
rotic plaques present a mismatch. This may be due to the 'cooling effect' of blood flow. In
order to test this hypothesis we designed a new balloon-thermogaphy catheter for tem-
perature measurements during coronary flow interruption. Method: A thermistor probe is
positioned at the distal segment of the catheter. Exactly opposite is placed a balloon.
During balloon inflation coronary flow is progressively interrupted. We studied 10 patients
with effort angina. Coronary flow velocity was continuously recorded. Temperature was
recorded at the proximal vessel wall and at the lesion before, during and after complete
interruption of blood flow. TDb was assigned as the difference between the background
and the maximal temperature during and after balloon inflation. TDl was assigned as the
difference between the atherosclerotic lesion and the proximal vessel wall. Results: TDb
during and after balloon inflation was 0.01±0.01 and -0.003±-0.01°C (p<0.001) respec-
tively. TDl was 0.07±0.04°C at baseline, 0.17±0.06°C (59.3±11.8% increase) during and
0.07±0.05°C after flow interruption (p<0.001)(Figure). TDl was greater than TDb during
and after obstruction of flow (p<0.001). Conclusions: In vivo atherosclerotic plaque tem-
perature recording with this new balloon-thermography catheter introduces a new
method for the detection of thermal heterogeneity in plaques and possibly resolves the
issue of 'cooling effect' of blood flow. 
POSTER SESSION
1156 
Carotid Stenting: Immediate and Late 
Outcomes
Tuesday, March 09, 2004, 3:00 p.m.-5:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 3:00 p.m.-4:00 p.m.
1156-59 Comparison of Interventional Versus Conservative 
Treatment of Isolated Ostial Lesions of Coronary 
Diagonal Branch Vessels: Results of a Prospective 
Single Center Trial
Martin Brueck, Martin Heidt, Wilfried Kramer, Josef Ludwig, Clinic of Wetzlar, Wetzlar, 
Germany, Justus-Liebig-University of Giessen, Giessen, Germany
Background. Percutaneous coronary intervention (PCI) of ostial stenosis of coronary
artery side branches are associated with reduced success and increased complications.
Therefore, it was the aim of the study to compare PCI with medical treatment of isolated
ostial stenosis of diagonal branches for reducing the incidence of ischemic events.
Methods. The study group comprised 302 patients with ostial stenosis > 75 % of the
diagonal branch and a vessel diameter > 2 mm of the diagonal branch without further sig-
nificant (< 50 %) coronary artery stenoses. The decision of medical or interventional
treatment was left to the discretion of the operator. 233 patients (77 %) were treated
medically (Group I), and 69 patients (23 %) underwent PCI (Group II). All patients went
into a database looking for death, myocardial infarction, recatheterization or angina at 12
months either by clinical examination or telephone call.
Results. Successful dilation of the ostial branch stenosis was obtained in 65 of 69
patients of Group II (94 %). In-hospital clinical outcome (death, acute myocardial infarc-
tion, refractory angina) were not different between both strategies. At 12 months follow-
up, 51 of 233 patients of Group I (22 %) were rehospitalized due to cardiac complaints
compared to 38 of 59 patients (55 %) of Group II (p < 0.001). 45 patients of Group I (19
%) and 32 of Group II (46 %) underwent recatheterization (p < 0.001). In 19 patients of
Group I (8 %) and 16 of Group II (23 %) (re-)PCI was necessary (p = 0.001). There were
no significant differences concerning death and myocardial infarction between both
groups after 12 months. Interventional treatment did not result in a higher incidence of
freedom of angina (41 %) compared with medical treatment (56 %; p = 0.255).
Conclusion. Medical treatment of isolated ostial stenosis of diagonal branches is an
alternative to percutaneous intervention without higher incidence of death or myocardial
infarction at 12 months follow-up. Interestingly, patients with isolated ostial stenosis of
diagonal branches treated by PCI showed a significantly higher probability of rehospital-
ization, recatheterization and re-PCI compared to medically treated patients.
1156-60 Predilatation Before Distal Protection Device Placement 
in Stenting Carotid Arteries Is Successful and Not 
Associated With Adverse Outcome
Giora Weisz, Jiri J. Vitek, Christina Brennan, Ian Dalagin, Gary Roubin, Sriram S. Iyer, 
Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research 
Foundation, New York, NY
Background: The use of distal protection devices (DPD) is gaining growing acceptance
as standard therapy to prevent distal embolization during carotid artery stenting (CAS). It
is optimal to have the device deployed during all phases of intervention, but this may not
be possible in tight and complex lesions, in which device crossing may be difficult. We
therefore examined whether the need for balloon pre-dilatation prior to lesion crossing
18 Gy (N=10) 22 Gy (N=10) 25 Gy (N=10) Total % (n=30)
Binary Restenosis % 11 12.5 10 11
Late Loss (mm) 0.43±0.78 -0.18±0.24 0.18±1.42 0.14±0.88
TLR 1 (10%) 1 (10%) 2 (20%) 4 (13%)
TVR 3 (30%) 1 (10%) 3 (30%) 7 (23%)
